Related references
Note: Only part of the references are listed.T-cell immunoglobulin- and mucin-domain-containing molecule-4 maintains adipose tissue homeostasis by orchestrating M2 macrophage polarization via nuclear factor kappa B pathway
Lu Ding et al.
IMMUNOLOGY (2023)
Immunotherapies for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy
Meng Wang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2022)
Metabolic Regulation of Macrophage Activation
Ourania Kolliniati et al.
JOURNAL OF INNATE IMMUNITY (2022)
Polarization of Tumor-Associated Macrophages Promoted by Vitamin C-Loaded Liposomes for Cancer Immunotherapy
Zhaoyu Ma et al.
ACS NANO (2022)
Hepatocellular carcinoma
Arndt Vogel et al.
LANCET (2022)
TMP195 Exerts Antitumor Effects on Colorectal Cancer by Promoting M1 Macrophages Polarization
Yicheng Han et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Macrophage-Based Approaches for Cancer Immunotherapy
Nicholas R. Anderson et al.
CANCER RESEARCH (2021)
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells
Benjamin Ruf et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Inducing immune tolerance with dendritic cell-targeting nanomedicines
Anna Cifuentes-Rius et al.
NATURE NANOTECHNOLOGY (2021)
Polystyrene microplastics cause granulosa cells apoptosis and fibrosis in ovary through oxidative stress in rats
Ru An et al.
TOXICOLOGY (2021)
Targeted PD-L1 PLGA/liposomes-mediated luteolin therapy for effective liver cancer cell treatment
Xinqiao Cao et al.
JOURNAL OF BIOMATERIALS APPLICATIONS (2021)
Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity
Andrew Chow et al.
CANCER CELL (2021)
Manipulation of TAMs functions to facilitate the immune therapy effects of immune checkpoint antibodies
Yang Liu et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Tunnelled Peritoneal Catheter for Malignant Ascites-An Open-Label, Prospective, Observational Trial
Golo Petzold et al.
CANCERS (2021)
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
Xu Lei et al.
CANCER LETTERS (2020)
Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer
Anders Etzerodt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Modulating inflammatory macrophages with an apoptotic body-inspired nanoparticle
Chelsea A. Kraynak et al.
ACTA BIOMATERIALIA (2020)
miR-145 Inhibits Th9 Cell Differentiation by Suppressing Activation of the PI3K/Akt/mTOR/p70S6K/HIF-1α Pathway in Malignant Ascites from Liver Cancer
You-Yi Huang et al.
ONCOTARGETS AND THERAPY (2020)
Tim-4 in Health and Disease: Friend or Foe?
Wen Liu et al.
FRONTIERS IN IMMUNOLOGY (2020)
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma
Hailong Sheng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Predictors of Postoperative Ascites After Hepatic Resection in Patients With Hepatocellular Carcinoma
Norifumi Harimoto et al.
ANTICANCER RESEARCH (2020)
Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy
Yan Zhao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Targeting STAT3 in Cancer Immunotherapy
Sailan Zou et al.
MOLECULAR CANCER (2020)
Active targeting liposome-PLGA composite for cisplatin delivery against cervical cancer
Paweena Dana et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2020)
Tolerogenic properties of CD206+ macrophages appeared in the sublingual mucosa after repeated antigen-painting
Yue Yang et al.
INTERNATIONAL IMMUNOLOGY (2020)
Turning Cold into Hot: Firing up the Tumor Microenvironment
Qianqian Duan et al.
TRENDS IN CANCER (2020)
Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer
Sha Zhao et al.
CANCER IMMUNOLOGY RESEARCH (2019)
M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds
Youhan Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes
Shoji Maeda et al.
SCIENCE (2019)
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Amira A. Barkal et al.
NATURE (2019)
Iron chelated melanin-like nanoparticles for tumor-associated macrophage repolarization and cancer therapy
Lei Rong et al.
BIOMATERIALS (2019)
The Immunology of Macrophage Activation Syndrome
Courtney B. Crayne et al.
FRONTIERS IN IMMUNOLOGY (2019)
Management of ascites and hepatorenal syndrome
Salvatore Piano et al.
HEPATOLOGY INTERNATIONAL (2018)
Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents
Matteo Santoni et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
The biology of serous cavity macrophages
Calum C. Bain et al.
CELLULAR IMMUNOLOGY (2018)
Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies
Ahmed Sabt et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Tim-4 promotes the growth of colorectal cancer by activating angiogenesis and recruiting tumor-associated macrophages via the PI3K/AKT/mTOR signaling pathway
Xiao Tan et al.
CANCER LETTERS (2018)
Cellular uptake mechanism and clearance kinetics of fluorescence-labeled glycyrrhetinic acid and glycyrrhetinic acid-modified liposome in hepatocellular carcinoma cells
Yuqi Sun et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2017)
Immune oncology in hepatocellular carcinoma-hype and hope
Marcus-Alexander Woerns et al.
LANCET (2017)
Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
Jennifer L. Guerriero et al.
NATURE (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
Sorafenib: A Review in Hepatocellular Carcinoma
Gillian M. Keating
TARGETED ONCOLOGY (2017)
A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer
Ayman Shafei et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Toxicidad asociada a la inhibición de EGFR: Revisión y aspectos clave del manejo de afatinib
Álvaro Taus
MEDICINA CLINICA (2016)
CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer
Dong-Yu Gao et al.
BIOMATERIALS (2015)
Tim-3 and Tim-4 as the potential targets for antitumor therapy
Lin Cheng et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
The Role of Relative Lymphocyte Count as a Biomarker for the Effect of Catumaxomab on Survival in Malignant Ascites Patients: Results from a Phase II/III Study
Markus M. Heiss et al.
CLINICAL CANCER RESEARCH (2014)
Fragile TIM-4-expressing tissue resident macrophages are migratory and immunoregulatory
Thomas B. Thornley et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
PLGA/Liposome Hybrid Nanoparticles for Short-Chain Ceramide Delivery
Peng Zou et al.
PHARMACEUTICAL RESEARCH (2014)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Palliative Chemotherapy for Malignant Ascites Secondary to Ovarian Cancer
Yuliya Malayev et al.
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE (2012)